Stevanato Group Soars 18.81%, Hits Intraday High of $17.57

Stevanato Group SpA, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 18.81% on March 4, 2026. The stock reached an intraday high of USD 17.57, marking a notable performance against the backdrop of a declining S&P 500, which fell by 0.43% on the same day. In terms of performance metrics, Stevanato Group has shown resilience over the past week, with a 14.38% increase, while its one-month performance stands at 15.97%. However, the company has faced challenges over the longer term, with a one-year decline of 9.42% and a year-to-date drop of 13.02%. Despite these fluctuations, Stevanato Group maintains a strong financial position, highlighted by a low Debt to EBITDA ratio of 0.73 times and a robust return on equity (ROE) of 14.35%. The company has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 25.12%. While it has reported negative results for the last five consecutive quarters, its management efficiency and ability to service debt remain commendable.